Work

Characteristics and outcomes of patients with HCC treated with atezolizumab/bevacizumab, stratified by second line therapy

Year: 2026

Type: article

Study design: Observational Study

Source: Future Oncology

DOI: 10.1080/14796694.2026.2614306

Authors: Amit G. Singal, Kirhan Özgürdal, Zdravko Vassilev, Federica Pisa, William S. John, Taavy A. Miller, Prathamesh Pathak, Sarah Gordon, Bruce Feinberg, Xiaoyun Pan

Institutions: The University of Texas Southwestern Medical Center, Bayer (Germany), Cardinal Health (United States)

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7124730804

FWCI:

Cites: 28

Cited by:

Related to: